The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

AC1NSKBE     4-[6-methoxy-2-(4- methoxyphenyl)benzofuran...

Synonyms: CHEMBL411481, SureCN3736014, CTK8E8959, KB-188548, LY-320135, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of LY320135


High impact information on LY320135

  • A second CB1 receptor antagonist, LY320135 (6 mg/kg), also significantly improved neurological function [2].
  • LY320135 is a selective antagonist for the brain CB1 receptor, having greater than 70-fold higher affinity for the CB1 than the peripheral CB2 receptor [3].

Anatomical context of LY320135

  • The Ki values for LY320135 at the CB1 and CB2 receptors, transfected and stably expressed in cell lines, were 224 nM and > 10 microM, respectively [3].


  1. Cannabinoid CB1 receptors fail to cause relaxation, but couple via Gi/Go to the inhibition of adenylyl cyclase in carotid artery smooth muscle. Holland, M., John Challiss, R.A., Standen, N.B., Boyle, J.P. Br. J. Pharmacol. (1999) [Pubmed]
  2. Anandamide content is increased and CB1 cannabinoid receptor blockade is protective during transient, focal cerebral ischemia. Muthian, S., Rademacher, D.J., Roelke, C.T., Gross, G.J., Hillard, C.J. Neuroscience (2004) [Pubmed]
  3. LY320135, a novel cannabinoid CB1 receptor antagonist, unmasks coupling of the CB1 receptor to stimulation of cAMP accumulation. Felder, C.C., Joyce, K.E., Briley, E.M., Glass, M., Mackie, K.P., Fahey, K.J., Cullinan, G.J., Hunden, D.C., Johnson, D.W., Chaney, M.O., Koppel, G.A., Brownstein, M. J. Pharmacol. Exp. Ther. (1998) [Pubmed]
WikiGenes - Universities